» Articles » PMID: 20554718

Diabetes and Cancer: a Consensus Report

Overview
Publisher Wiley
Specialty Oncology
Date 2010 Jun 18
PMID 20554718
Citations 403
Authors
Affiliations
Soon will be listed here.
Abstract

Epidemiologic evidence suggests that cancer incidence is associated with diabetes as well as certain diabetes risk factors and treatments. This consensus statement of experts assembled jointly by the American Diabetes Association and the American Cancer Society reviews the state of science concerning 1) the association between diabetes and cancer incidence or prognosis; 2) risk factors common to both diabetes and cancer; 3) possible biologic links between diabetes and cancer risk; and 4) whether diabetes treatments influence the risk of cancer or cancer prognosis. In addition, key unanswered questions for future research are posed.

Citing Articles

Screening of common genomic biomarkers to explore common drugs for the treatment of pancreatic and kidney cancers with type-2 diabetes through bioinformatics analysis.

Ajadee A, Mahmud S, Sarkar A, Noor T, Ahmmed R, Haque Mollah M Sci Rep. 2025; 15(1):7363.

PMID: 40025145 PMC: 11873208. DOI: 10.1038/s41598-025-91875-3.


Global disease burden of breast cancer attributable to high fasting plasma glucose: a comprehensive analysis from the global burden of disease study.

Zhang J, He J, Lu Y, Lan T Front Endocrinol (Lausanne). 2025; 16:1498207.

PMID: 40017691 PMC: 11864957. DOI: 10.3389/fendo.2025.1498207.


A Narrative Review: Relationship Between Glycemic Variability and Emerging Complications of Diabetes Mellitus.

Wang X, Cao Y Biomolecules. 2025; 15(2).

PMID: 40001491 PMC: 11853042. DOI: 10.3390/biom15020188.


Breast cancer shares many epidemiological, lifestyle, and local hormonal and metabolic underpinnings with endometrial and ovarian cancer: a narrative review.

Rodriguez Y, Koomson A, Perry R Transl Breast Cancer Res. 2025; 6:8.

PMID: 39980815 PMC: 11836739. DOI: 10.21037/tbcr-24-39.


Metformin combined with CB-839 specifically inhibits KRAS-mutant ovarian cancer.

Wu H, Zhang J, Wang Q, Li Z, Li L, Xie Y Sci Rep. 2025; 15(1):6072.

PMID: 39972191 PMC: 11840008. DOI: 10.1038/s41598-025-90963-8.